FFGRX — Emerald Growth Fund
Data updated: 2026-09-24
FFGRX — Emerald Growth Fund. Money Market · $1.48B AUM · 1.08% expense ratio. Holdings, fees, performance and SEC filings.
FFGRX Fund Overview
FFGRX — Emerald Growth Fund is a US mutual fund managed by Rbb Fund, Inc., categorised as Money Market. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Rbb Fund, Inc.
- Category: Money Market
- Assets under management: $1.48B
- Ticker: FFGRX
- SEC CIK: 0000831114
- SEC series ID: S000093696
- Share class ID: C000262143
FFGRX Investment Objective and Strategy
Emerald Growth Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Rbb Fund, Inc..
Investment objective
Emerald Growth Fund (the Fund) seeks long-term growth through capital appreciation.
Principal investment strategy
The Emerald Growth Fund has adopted an investment policy that it will, under normal conditions, invest at least 80% of the value of its assets (net assets plus the amount of any borrowings for investment purposes) in equity securities of U.S. and foreign companies, principally common stocks and preferred stocks, identified by the Adviser as having growth characteristics. In identifying investments with growth characteristics, the Adviser utilizes a fundamental approach to choosing securities: the research staff of Emerald conducts company-specific research analysis, taking into account a companys revenue and earnings growth rates and the financial, operating, and market characteristics that distinguish a company from other companies. The Funds policy to invest at least 80% of its assets in such a manner is non-fundamental, which means that it may be changed without shareholder approval.
Shareholders will receive 60 days prior written notice of any change to this policy. The Fund can invest in companies from a wide range of industries and of market capitalizations. The Fund may emphasize investments in smaller companies, which are defined by the Adviser as those having a market capitalization equal to or less than that of the largest companies in the Russell 2000 Index. As of June 30, 2025, the Russell 2000 Index included securities issued by companies that ranged in size between $2 million and $15.85 billion. The Fund may also invest in the other investment companies, principally money market funds, exchange-traded funds (ETFs), unit investment trusts, closed-end funds, and business development companies. The Fund intends to invest a portion of these assets in the securities of affiliated ETFs advised or sub-advised by the Adviser (each, an Underlying ETF).
The Fund does not have a policy with respect to investing a certain portion of its assets in any particular sector, but may emphasize investments in the healthcare, technology, and industrial sectors. While the Fund may directly invest in the securities of companies within the healthcare sector, the Adviser intends for the Fund to gain exposure to the healthcare sector in part through the use of such Underlying ETFs, primarily the F/m Emerald Life Sciences Innovation ETF (the Life Sciences ETF). The Fund does not have a policy with respect to the amount of the Funds portfolio that will be allocated to the Life Sciences ETF, but generally the Adviser expects approximately 5% of the Funds portfolio to be allocated to the Life Sciences ETF, calculated at the time of investment. The Fund may invest in foreign companies directly and through American Depository Receipts (ADRs).
The Fund generally sells investments when the Adviser concludes that better investment opportunities exist in other securities, the security is fully valued, or the issuers circumstances or the political or economic outlook have changed.
FFGRX Holdings
Top 10 holdings of Emerald Growth Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| F/m Emerald Life Sciences Inno | 6.14% |
| U.S. Bank Money Market Deposit Account | 1.98% |
| AAR Corp | 1.95% |
| InterDigital Inc | 1.83% |
| Travere Therapeutics Inc | 1.69% |
| VSE Corp | 1.68% |
| Mercury Systems Inc | 1.63% |
| Corcept Therapeutics Inc | 1.54% |
| ESCO Technologies Inc | 1.51% |
| Sensient Technologies Corp | 1.47% |
FFGRX Portfolio Allocation
Asset-class allocation of Emerald Growth Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.4% |
| Cash & Equivalents | 2.0% |
FFGRX Performance
Total returns for FFGRX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -1.2% |
FFGRX Costs and Fees
FFGRX costs about $108 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.08%
- Gross expense ratio: 1.12%
- Portfolio turnover: 54%
FFGRX Debt Constituents
No individual debt constituents are reported in Emerald Growth Fund's latest SEC N-PORT filing.
FFGRX Prospectus and SEC Filings
Official Emerald Growth Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Money Market funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.